Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thermal ablation of tumor tissue via coagulative necrosis" is not a molecular target, receptor, or protein, but rather a therapeutic process used in cancer treatment. This method involves applying high temperatures (typically above 60°C) directly to tumors using modalities such as radiofrequency ablation (RFA), microwave ablation, or high-intensity focused ultrasound (HIFU). The elevated temperature causes rapid denaturation of proteins and disruption of cell membranes, leading to coagulative necrosis—a form of cell death where the basic architecture of dead tissue is preserved for several days. This process destroys cancer cells within the targeted area while aiming to spare surrounding healthy tissues as much as possible[5][7][9]. The effectiveness and extent of coagulation depend on factors like tissue type, vascularity, and electrical conductivity[1]. While highly effective for certain localized tumors and minimally invasive compared with surgery, it is not itself a druggable target but rather an endpoint or effect achieved by various energy-based devices. Note: This entry does not correspond to a canonical molecular target such as a receptor or enzyme; it describes an outcome/process. Therefore, "is_target" should be marked false and "is_incorrect" true for purposes requiring structured molecular target data.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thermal ablation-induced coagulative necrosis (of tumor tissue).